Senti Biosciences Holdings Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,342 | -37,419 | -18,722 | -58,210 | -40,000 |
| Depreciation Amortization | 3,955 | 2,140 | 929 | 3,920 | 2,976 |
| Accounts receivable | 509 | 64 | -135 | -131 | -363 |
| Accounts payable and accrued liabilities | 465 | 885 | 280 | 186 | 93 |
| Other Working Capital | -1,316 | -733 | -1,613 | 13,904 | 8,809 |
| Other Operating Activity | 3,371 | 5,084 | 2,957 | 5,435 | 2,595 |
| Operating Cash Flow | $-45,358 | $-29,979 | $-16,304 | $-34,896 | $-25,890 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,010 | 19,010 | -2,990 | -40,585 | 0 |
| PPE Investments | -12,034 | -10,176 | -6,507 | -41,374 | -32,841 |
| Investing Cash Flow | $29,976 | $8,834 | $-9,497 | $-81,959 | $-32,841 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,175 | 5,175 |
| Debt Repayment | -85 | -62 | -35 | N/A | N/A |
| Common Stock Issued | 308 | 308 | N/A | 1,400 | 521 |
| Other Financing Activity | 0 | 0 | 0 | 111,976 | 111,979 |
| Financing Cash Flow | $223 | $246 | $-35 | $118,551 | $117,675 |
| Beginning Cash Position | 60,987 | 60,987 | 60,987 | 59,291 | 59,291 |
| End Cash Position | 45,828 | 40,088 | 35,151 | 60,987 | 118,235 |
| Net Cash Flow | $-15,159 | $-20,899 | $-25,836 | $1,696 | $58,944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,358 | -29,979 | -16,304 | -34,896 | -25,890 |
| Capital Expenditure | -12,034 | -10,176 | -6,507 | -41,374 | -32,841 |
| Free Cash Flow | -57,392 | -40,155 | -22,811 | -76,270 | -58,731 |